The GLP is committed to full transparency. Download and review our Annual Report.

Non-invasive prenatal testing: The holy grail of prenatal genetic testing?

| | August 16, 2013

I’ve been pregnant twice in my 40s and am expecting my fifth child in November. Like most women my age, I was offered — indeed encouraged to have — an amniocentesis orchorionic villous sampling (CVS). But I worry about about procedure-related miscarriage — the small chance that an invasive test (involving a needle in the uterus) could cause the loss of an otherwise healthy child.

Perhaps that’s why I felt such gratitude when I was offered non-invasive prenatal testing (NIPT), a test that can, through a single blood sample, determine with accuracy whether a fetus carries the genes for one of three major chromosome abnormalities. I’ve never been more eager to roll up my sleeve.

Read the full, original story here: I Found the ‘Holy Grail’ of Prenatal Testing

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend